Long-term outcome of reduced intensity conditioning allogeneic stem cell transplantation in advanced stage mycosis fungoides and Sezary syndrome

被引：0
|
作者：
Onida, F. [1 ]
Saporiti, G. [1 ]
Tagliaferri, E. [1 ]
Iacobelli, S. [2 ]
Violetti, S. Alberti [3 ]
Soverini, G. [1 ]
Corti, L.
Vincenti, D. [1 ]
Gregorini, A. I. [1 ]
Berti, E.
Cortelezzi, A. [1 ]
机构：
[1] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Oncohematol Unit, BMT Ctr, Milan, Italy
[2] Univ Roma Tor Vergata, Dept Biol, Rome, Italy
[3] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P617
引用
收藏
页码：S448 / S449
页数：2
相关论文
共 50 条
  • [31] Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma
    El-Cheikh, Jean
    Crocchiolo, Roberto
    Furst, Sabine
    Stoppa, Anne-Marie
    Ladaique, Patrick
    Faucher, Catherine
    Calmels, Boris
    Lemarie, Claude
    De Colella, Jean-Marc Schiano
    Granata, Angela
    Coso, Diane
    Bouabdallah, Reda
    Chabannon, Christian
    Blaise, Didier
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) : 370 - 374
  • [32] Long-Term Outcome of Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sezary Syndrome: A European Society for Blood and Marrow Transplantation Lymphoma Working Party Extended Analysis
    Duarte, Rafael F.
    Boumendil, Ariane
    Onida, Francesco
    Gabriel, Ian
    Arranz, Reyes
    Arcese, William
    Poire, Xavier
    Kobbe, Guido
    Narni, Franco
    Cortelezzi, Agostino
    Olavarria, Eduardo
    Schmitz, Norbert
    Sureda, Anna
    Dreger, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (29) : 3347 - 3348
  • [33] Durable Remission of Refractory and Advanced Stage Mycosis Fungoides/Sezary Syndrome (MF/SS) Utilizing an " Outpatient" Alemtuzumab and Fludarabine- Based Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT)
    Phuong Vo
    Srinivasan, Ramaprasad
    Purev, Enkhtsetseg
    McDuffee, Emily
    Cook, Lisa
    Worthy, Tatyana
    Hawks, Geri
    Patricia, Prince
    Shalabi, Reem
    Wells, Brian
    Reger, Robert
    Khuu, Hanh
    Stroncek, David
    Tian, Xin
    Geller, Nancy
    Aue, Georg
    Childs, Richard
    BLOOD, 2017, 130
  • [34] Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantation
    Masood, N
    Russell, KJ
    Olerud, JE
    Sabath, DE
    Sale, GE
    Doney, KC
    Flowers, MED
    Fefer, A
    Thompson, JA
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (01) : 140 - 145
  • [35] Safety and outcome of allogeneic stem cell transplantation in mycosis fungoides and Sezary syndrome: A seven-year tertiary center analysis.
    Toprak, Selami Kocak
    Seval, Guldane Cengiz
    Atilla, Erden
    Bozdag, Sinem Civriz
    Yuksel, Meltem Kurt
    Topcuoglu, Pervin
    Akay, Bengu Nisa
    Sanli, Hatice
    Gurman, Gunhan
    Ozcan, Muhit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] Evidence of graft-versus-leukaemia following allogeneic haematopoietic stem cell transplantation in patients with advanced mycosis fungoides and Sezary syndrome
    Onida, F.
    Saporiti, G.
    Berti, E.
    Della Volpe, A.
    Annaloro, C.
    Tagliaferri, E.
    Vezzoli, P.
    Usardi, P.
    Deliliers, G. Lambertenghi
    BONE MARROW TRANSPLANTATION, 2008, 41 : S173 - S174
  • [37] Complete remission of late stage mycosis Fungoides/Sezary Syndrome following allogeneic transplantation.
    Donato, M
    Kurzrock, R
    Champlin, R
    Saliba, RM
    Duvic, M
    BLOOD, 2003, 102 (11) : 731A - 731A
  • [38] Long-term complications and quality of life after reduced-intensity conditioning allogeneic stem cell transplantation
    Clavert, A.
    Peric, Z.
    Cahu, X.
    Chevallier, P.
    Brissot, E.
    Malard, F.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Dubruille, V.
    Le Gouill, S.
    Mahe, B.
    Gastinne, T.
    Blin, N.
    Harousseau, J-L.
    Moreau, P.
    Milpied, N.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S52 - S52
  • [39] ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED MYCOSIS FUNGOIDES AND SEZARY SYNDROME: A RETROSPECTIVE ANALYSIS INCLUDING 63 CONSECUTIVE PATIENTS WITH LONG-TERM MEDIAN FOLLOW-UP
    Onida, Francesco
    Cavallaro, Francesca
    Violetti, Silvia Alberti
    Goldaniga, Maria
    Barbullushi, Kordelia
    Serpenti, Fabio
    Iacobelli, Simona
    Croci, Giorgio Alberto
    Simontacchi, Gabriele
    Passamonti, Francesco
    Berti, Emilio
    Saporiti, Giorgia
    BONE MARROW TRANSPLANTATION, 2024, 59 : 103 - 103
  • [40] Reduced Intensity Conditioning in Allogeneic Stem Cell Transplantation for AML With Down Syndrome
    Muramatsu, Hideki
    Sakaguchi, Hirotoshi
    Taga, Takashi
    Tabuchi, Ken
    Adachi, Souichi
    Inoue, Masami
    Kitoh, Toshiyuki
    Suminoe, Aiko
    Yabe, Hiromasa
    Azuma, Eichi
    Shioda, Yoko
    Ogawa, Atsushi
    Kinoshita, Akitoshi
    Kigasawa, Hisato
    Osugi, Yuko
    Koike, Kazutoshi
    Kawa, Keisei
    Kato, Koji
    Atsuta, Yoshiko
    Kudo, Kazuko
    PEDIATRIC BLOOD & CANCER, 2014, 61 (05) : 925 - 927
12345